Mark Tepper joined Stuart Varney for the full hour on Fox Business to discuss key market drivers and investment opportunities. He explains why another buy-the-dip moment may be on the horizon as tariff refund potential and fiscal uncertainty could shake markets. Mark shares insights on Freeport-McMoRan as a copper play tied to AI infrastructure, and highlights Vertex Pharmaceuticals’ non-opioid painkiller as a long-term growth catalyst. The segment also explores the push to manufacture AI chips in the U.S. under a revised Chips Act, and finishes with commentary on generational shifts in mobile payments and crypto adoption.